William Pao
Fortuna: - $ al 30/06/2026
Fortuna: - $ al 30/06/2026
William Pao is the founder of Revelio Therapeutics, Inc., founded in 2024, where he holds the title of Chief Executive Officer.
Dr. Pao is also the founder of My Cancer Genome.
Current jobs include Director at Transcelerate Biopharma, Inc., Director at Obsidian Therapeutics, Inc., Director at Alentis Therapeutics AG, and Independent Non-Executive Director at Immunocore Holdings Plc starting in 2025.
Former jobs include Professor and Director of the Hematology & Oncology Division at Vanderbilt University, Director at the American Association for Cancer Research, Director of Personalized Cancer Medicine at The Vanderbilt-Ingram Cancer Center, Chief Development Officer and Executive Vice President at Pfizer Inc. from 2022 to 2023, and Head of Pharma Research & Early Development at Roche Holding AG and F.
Hoffmann-La Roche Ltd. from 2014 to 2022.
Education includes undergraduate studies at Harvard University and a doctorate from Yale University.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 27/05/2026 | 0 ( -.--% ) | - $ | 30/06/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| IMMUNOCORE HOLDINGS PLC | Director/Miembro de la Junta | 25/02/2025 |
Transcelerate Biopharma, Inc.
Transcelerate Biopharma, Inc. BiotechnologyHealth Technology Provides biopharmaceutical research services | Director/Miembro de la Junta | - |
Obsidian Therapeutics, Inc.
Obsidian Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops TIL cell therapies for the treatment of patients with solid tumors | Director/Miembro de la Junta | - |
Alentis Therapeutics AG
Alentis Therapeutics AG BiotechnologyHealth Technology Operates as a clinical-stage biotech company that develops therapies to treat cancer and reverse fibrosis | Director/Miembro de la Junta | - |
Launchpad Therapeutics, Inc.
Launchpad Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Develops novel therapeutics | Director Ejecutivo | 01/05/2024 |
| Empresas | Cargo | Fin |
|---|---|---|
| PFIZER INC. | Corporate Officer/Principal | 15/08/2023 |
| ROCHE HOLDING AG | Corporate Officer/Principal | 18/03/2022 |
F. Hoffmann-La Roche Ltd.
F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Corporate Officer/Principal | 01/03/2022 |
My Cancer Genome | Fundador | - |
| ░░░░░░░░ ░░░░░░░░░░░ ░░░ ░░░░░░ ░░░░░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░ ░░░░░ | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 14 |
|---|---|
Pfizer Inc.
Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
Roche Holding AG
Roche Holding AG Pharmaceuticals: MajorHealth Technology Operates as a research-focused healthcare company with combined focus in pharmaceuticals and diagnostics | Health Technology |
F. Hoffmann-La Roche Ltd.
F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Harvard University
Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vanderbilt University
Vanderbilt University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Yale University
Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
American Association for Cancer Research
American Association for Cancer Research Miscellaneous Commercial ServicesCommercial Services Engages in research, education, communication and collaboration to prevent and cure cancer | Commercial Services |
The Vanderbilt-Ingram Cancer Center
The Vanderbilt-Ingram Cancer Center Hospital/Nursing ManagementHealth Services Engages in prevention, diagnosis and treatment of cancer | Health Services |
Transcelerate Biopharma, Inc.
Transcelerate Biopharma, Inc. BiotechnologyHealth Technology Provides biopharmaceutical research services | Health Technology |
Obsidian Therapeutics, Inc.
Obsidian Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops TIL cell therapies for the treatment of patients with solid tumors | Health Technology |
Alentis Therapeutics AG
Alentis Therapeutics AG BiotechnologyHealth Technology Operates as a clinical-stage biotech company that develops therapies to treat cancer and reverse fibrosis | Health Technology |
Immunocore Holdings Plc
Immunocore Holdings Plc BiotechnologyHealth Technology Operates as a biotechnology company which develops immunotherapies | Health Technology |
Launchpad Therapeutics, Inc.
Launchpad Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Develops novel therapeutics | Commercial Services |
My Cancer Genome | Electronic Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.